Babylon (NYSE:BBLN) Upgraded to “Hold” by Zacks Investment Research

Babylon (NYSE:BBLNGet Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Monday, Zacks.com reports.

According to Zacks, “Babylon Holdings Limited is a digital healthcare company. Babylon Holdings Limited, formerly known as Alkuri Global Acquisition Corp., is based in PALO ALTO, Calif. “

A number of other research analysts have also recently issued reports on the stock. Canaccord Genuity Group reduced their price objective on shares of Babylon from $14.00 to $8.00 and set a “buy” rating for the company in a report on Friday, March 11th. Deutsche Bank Aktiengesellschaft started coverage on shares of Babylon in a report on Wednesday, January 12th. They set a “buy” rating and a $9.00 price objective for the company. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $10.50.

Shares of NYSE BBLN traded down $0.02 during mid-day trading on Monday, reaching $3.44. 199,848 shares of the company’s stock traded hands, compared to its average volume of 155,505. The business has a 50-day moving average of $4.63. Babylon has a 1-year low of $3.33 and a 1-year high of $16.00. The company has a debt-to-equity ratio of 1.02, a current ratio of 2.37 and a quick ratio of 2.37.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Wells Fargo & Company MN bought a new stake in Babylon in the fourth quarter worth about $58,000. Mirabella Financial Services LLP bought a new stake in Babylon in the fourth quarter worth about $63,000. JPMorgan Chase & Co. bought a new stake in Babylon in the fourth quarter worth about $63,000. Goldman Sachs Group Inc. bought a new stake in Babylon in the fourth quarter worth about $66,000. Finally, Penserra Capital Management LLC bought a new stake in Babylon in the fourth quarter worth about $137,000. 62.45% of the stock is currently owned by institutional investors.

Babylon Company Profile (Get Rating)

Babylon Holdings Limited operates as a digital healthcare company. The company provides assistance to navigate the health system by connecting patients digitally to the clinicians. It operates in the United Kingdom, the United States, the Asia Pacific, Canada, and internationally. The company was founded in 2013 and is headquartered in London, the United Kingdom.

Featured Stories

Get a free copy of the Zacks research report on Babylon (BBLN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Babylon (NYSE:BBLN)

Receive News & Ratings for Babylon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Babylon and related companies with MarketBeat.com's FREE daily email newsletter.